$KMPR: Kemper Announces Schedule for Fourth Quarter 2018 Earnings Call …

Date: Monday, January 14th, 2019

Stock(s) mentioned:

Source: Business Wire (https://www.businesswire.com)

Summary: CHICAGO–(BUSINESS WIRE)–Kemper Corporation (NYSE: KMPR) announced today that before the markets open on Monday, February 11, 2019, Kemper will …

Full article address: https://www.businesswire.com/news/home/20190114005270/en/Kemper-Announces-Schedule-Fourth-Quarter-2018-Earnings

Related News:

$KMPR: Kemper Appoints Matthew A. Hunton as President of Kemper Auto

$KMPR: Kemper Corp (KMPR) CEO Joseph Lacher on Q1 2019 Results …

$KMPR: Kemper Corp (KMPR) Q1 2019 Earnings Call Transcript

$KMPR: Kemper Q1 reflects profit gains in specialty P&C

$KMPR: Kemper Reports Strong First Quarter 2019 Operating Results

$KMPR: Kemper Q1 2019 Earnings Preview

$KMPR $PVTL $CR $LOXO: Did Hedge Funds Drop The Ball On Semiconductor Manufacturing …

$KMPR $CR $LOXO: Were Hedge Funds Right About Flocking Into Kemper Corporation …

$KMPR: Kemper Appoints Cheryl Kingsfield Neal as President of Kemper Life

$KMPR: Should You Worry About Kemper Corporation’s (NYSE:KMPR) CEO …

$KMPR: Kemper Corp (KMPR) Q4 2018 Earnings Conference Call Transcript

Latest News:

$SPY $BABA: If a popular options strategy suddenly implodes, be ready to scoop up cheap blue chips

$GE: Is General Electric a Buy?

$HD $URBN: Home Depot, Target, HP, Best Buy and More Major Earnings …

$TMUS: Masayoshi Son: Genius or insane? Maybe neither

$DAL $ALK $LUV $NFLX $UAL: Delta’s test of free in-flight Wi-Fi may shame other airlines into offering service

$AVTR $FSLY $LK $LYFT $PINS $UBER: Why the IPO Boom Will Continue

$SBUX: Millions of Americans Could Miss Work Tomorrow After the ‘Game of Thrones’ Finale

$AMZN $OXY $APC $WFC $SRE: Want to invest like Warren Buffett? Here are the ins and outs of buying preferred stock

$TSLA $GM: Tesla fires could dampen electric car sales as industry ramps up EV production, auto analysts say

$ROKU $GH $CVNA: 3 Stocks That Have Doubled in 2019 — Are They Still Buys?

$AXSM: Here’s Why You’ll Regret Ignoring This Biotech Stock Rocket